Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Email: rkapur@hmpglobal.com

July 2017

|
Volume 25 Issue 7
The PA pressure sensor technology now is simple and easily implemented in the cath lab. Caveats aside, this looks like a game changer for our patients with difficult-to-manage CHF.
Given the rural nature of north Mississippi, we believe it is unique to support a high number of increasingly complex cardiovascular procedures at such a high level of competency. We face all issues with a multi-disciplinary team to discuss challenge…
The patient’s first presentation to the authors’ institution was via the emergency department with a Rutherford Class 6 ulcer.
Percutaneous coronary intervention (PCI) of vein grafts is associated with a higher rate of periprocedural myocardial infarction (MI), target vessel revascularization, and mortality compared to native vessel intervention.
Although hospital systems are quick to embrace the transradial approach due to its proven cost savings, improved outcomes, and an increase in same-day discharge, only a few have dedicated the resources to streamlining recovery post-TRA through dedica…
We present a case of a 44-year-old woman who presented with exertional dyspnea and was found to have a 7.0 cm x 3.5 cm right atrial mass on transthoracic echocardiogram that required surgical resection.
Since 2011 we have seen Medicare launch six bundled payment programs. …As 2016 ended, we began to see evidence of the effectiveness of bundled payments. 
Right ventricular perforation during emergent pericardiocentesis is an unfortunate but known complication of the procedure. However, right ventricular perforation with resultant endocardial and epicardial thrombi has never been described as a complic…
What would Andreas Gruentzig think about angioplasty 40 years later, given all of the regulatory restrictions and guideline revisions that directly impact the decisions in treating patients with coronary artery disease? 
With proper planning, a pre-development strategy, and a solid business plan, the Ambulatory CardioVascular Center is the next wave of delivering high-quality, efficient, endovascular, cardiology, and dialysis vascular access therapy to patients.